C
CalNeuro Research Group | Los Angeles, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BHV-7000
Brexpiprazole
Troriluzole
Psilocybin
BI 1358894
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is to determine the efficacy and safety of BHV-7000 in participants with Major Depressive Disorder (MDD)
Enrolling
Major Depressive Disorder
Drug: BHV-7000
Drug: Placebo
Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)
Enrolling
Treatment Resistant Depression
Drug: Psilocybin
The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).
Invitation-only
Major Depressive Disorder
Drug: BHV-7000
Trial sponsors
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems